Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04099173 · ClinicalTrials.gov registry record · NA
A Brief Mindfulness-Based Intervention for Suicidal Ideation
A NA study, sponsored by VA Salt Lake City Health Care System.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04099173: Completed NA study, sponsored by VA Salt Lake City Health Care System.
NCT04099173 is a NA study that has completed, run by VA Salt Lake City Health Care System. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04099173, a NA study, has completed, sponsored by VA Salt Lake City Health Care System.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The primary aim of this study is to determine whether a Brief Mindfulness-Based Intervention for Suicidal Ideation (MB-SI) is feasible and safe to implement. The secondary aims are short and longer-term reduction in suicidal ideation (SI) and/or suicide-related behaviors (SRBs) as well as improvements in mindfulness and emotional regulation measures compared to Treatment as Usual (TAU).
Primary Outcome
Determine if there is a significant difference in the Columbia Suicide Severity Rating Scale, among the MB-SI + TAU cohort compared to the TAU only cohort. The total Columbia Suicide Severity Rating Scale score can range from 0 to 25, with higher values indicating greater intensity. Longitudinal generalized linear mixed models will be used for the primary analyses. We estimate a total of two time points (baseline and one month follow-up) for the primary outcome.
Interventions
- BEHAVIORAL Brief Mindfulness Based Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2023-01-05 |
| Phase | NA |
What the finished NCT04099173 record still lists
NCT04099173 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Brief Mindfulness Based Intervention is the first listed.
NCT04099173 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04099173 about?
NCT04099173 is a clinical study titled "A Brief Mindfulness-Based Intervention for Suicidal Ideation". The primary aim of this study is to determine whether a Brief Mindfulness-Based Intervention for Suicidal Ideation (MB-SI) is feasible and safe to implement. The secondary aims are short and longer-term reduction in suicidal ideation (SI) and/or suicide-related behaviors (SRBs) as well as improvemen...
What is the current status of trial NCT04099173?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-09-01. Estimated completion is 2023-01-05.
What interventions are being tested in trial NCT04099173?
The interventions under investigation include: Brief Mindfulness Based Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04099173?
This trial is sponsored by VA Salt Lake City Health Care System, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04099173's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI